Valuation is often one of the first indicators used to assess a startup’s progress.

A higher valuation can signal investor confidence, growing market interest and expectations of future growth. For founders, it can also represent an important milestone in the company’s development.

But valuation and business maturity do not always progress at the same pace.

A DeepTech company can increase its valuation significantly while still facing fundamental questions about its commercial model, operational capacity or ability to scale.

This becomes particularly relevant between Seed and Series A, when companies must demonstrate that their technology can support a sustainable business.

For investors, understanding what sits behind a valuation is often more important than the number itself.

Valuation Reflects Expectations, Not Execution

Startup valuations are influenced by several factors, including market opportunity, technological differentiation, competitive dynamics and investor expectations.

In DeepTech, these expectations can be particularly significant.

A company may own valuable intellectual property, develop a technology with substantial market potential or operate in a sector attracting strong investment interest.

These characteristics can justify investor confidence in its future.

However, they do not necessarily demonstrate that the company has established the commercial and operational capabilities required to deliver that potential.

A successful pilot does not automatically translate into repeatable sales. Strong demand for a technology does not guarantee an effective go-to-market strategy. An experienced technical team may still need additional commercial and management capabilities.

Valuation incorporates assumptions about what a company could become.

Execution provides evidence of what it can achieve.

When Valuation Grows Faster Than the Business

Between Seed and Series A, DeepTech startups often face pressure to demonstrate rapid progress.

Investor interest can increase before the company has completed its commercial validation or established the operational structures needed for growth.

This can create a gap between valuation and actual business readiness.

For example, a company may achieve a significantly higher valuation while:

  • commercial traction remains dependent on a limited number of pilots
  • customer acquisition has not become repeatable
  • revenue forecasts rely on assumptions that have yet to be validated
  • operational processes are not prepared for expansion
  • the team lacks critical capabilities for the next stage of growth

None of these conditions necessarily means that the company lacks investment potential.

They do, however, affect its ability to deliver the growth implied by its valuation.

When additional capital enters at this stage, the company may be expected to accelerate before its commercial and operational foundations are sufficiently developed.

The challenge becomes more demanding as financial commitments increase and investors expect measurable progress towards the next funding round.

What Investors Should Look Beyond

Valuation is an important part of any investment decision. It influences ownership, dilution, return expectations and the economics of future rounds.

But it should be considered alongside a broader assessment of investment readiness.

For DeepTech companies, that assessment needs to examine several dimensions:

  • Commercial validation: Is there evidence of customer demand beyond initial interest or pilot activity?
  • Go-to-market execution: Does the company have a credible strategy for reaching and converting customers?
  • Operational readiness: Can the organisation manage the next stage of growth?
  • Capital efficiency: Is the company capable of translating investment into measurable progress?
  • Milestone definition: Are the objectives of the next funding period realistic and verifiable?
  • Scalability: Can the business expand without a disproportionate increase in costs or operational complexity?

These questions help investors distinguish between the potential reflected in a valuation and the company’s capacity to realise that potential.

They also provide a stronger basis for determining investment timing and capital requirements.

The Relationship Between Valuation and Capital Deployment

A higher valuation can benefit founders by reducing dilution and providing greater negotiating leverage.

For investors, however, it can also increase the importance of execution discipline.

When capital is invested at a valuation that anticipates substantial future growth, the company must deliver sufficient progress to support its next financing round.

If commercial milestones are delayed or operational costs rise faster than expected, that valuation can become difficult to sustain.

This is especially relevant in DeepTech, where clinical validation, regulatory approvals, industrial pilots or complex procurement processes can affect the pace of commercialisation.

Investment decisions therefore need to account for the company’s actual stage of development and the resources required to reach its next milestones.

Linking capital deployment to verified progress can help investors manage this transition more effectively.

It also encourages companies to focus on the commercial and operational achievements that support long-term value creation, rather than treating valuation growth as an objective in itself.

Execution Is What Ultimately Supports Valuation

A valuation represents a view of a company’s future at a particular moment.

As the business develops, that view is tested against results.

Can the company convert market interest into paying customers? Can it deliver consistently? Can it expand its operations while maintaining financial discipline? Can it demonstrate the progress required to attract the next round of institutional investment?

For DeepTech companies, answering these questions requires more than technological excellence.

It requires commercial validation, operational maturity and a clear relationship between investment and execution.

This is why valuation should never be considered in isolation when assessing a company’s readiness for growth.

A strong valuation may reflect significant potential. The company’s ability to turn that potential into business performance is what ultimately gives those expectations substance.

In DeepTech, valuation tells investors what the market believes a company can become. Execution shows what the company can actually deliver.